Diagnosis and treatment of early and locally advanced non-small-cell lung cancer: The 2019 AIOM (Italian Association of Medical Oncology) clinical practice guidelines
- PMID: 32062311
- DOI: 10.1016/j.critrevonc.2019.102862
Diagnosis and treatment of early and locally advanced non-small-cell lung cancer: The 2019 AIOM (Italian Association of Medical Oncology) clinical practice guidelines
Abstract
The Italian Association of Medical Oncology (AIOM) has developed clinical practice guidelines for the diagnosis and treatment of patients with early and locally advanced non-small cell lung cancer. In the current paper a panel of AIOM experts in the field of thoracic malignancies discussed these topics, analyzing available scientific evidences, with the final aim of providing a summary of clinical recommendations, which may guide physicians in their current practice.
Keywords: Clinical practice guidelines; Early disease; Locally advanced disease; Non-small cell lung cancer; Recommendations.
Copyright © 2020 Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest Silvia Novello, Department of Oncology, University of Turin, AOU San Luigi, Orbassano (Italy). COI: consultant and/or speaker's fee for Eli Lilly, MSD, Roche, BMS, Takeda, Pfizer, Abbvie, Celgene, AZ, Boehringer Ingelheim.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
